<DOC>
	<DOCNO>NCT00795158</DOCNO>
	<brief_summary>The purpose study determine effect desloratadine treatment quality life , daytime functioning , quality sleep , symptom , disease severity patient hive 6 week longer . Patients take desloratadine 1 month . Once week , patient fill questionnaire tell hive affect life . This questionnaire call Dermatology Life Quality Index DLQI . They also fill diary every day tell much itching , many hive , hive affect sleep daily activity . The patient doctor rat patient ' overall condition much relief patient get treatment .</brief_summary>
	<brief_title>How Desloratadine ( Clarinex , Aerius ) Affects Quality Life Patients With Chronic Idiopathic Urticaria ( Have Had Hives 6 Weeks Longer ) ( Study P02988 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Subjects must demonstrate willingness participate study comply procedure sign write informed consent . Subjects must &gt; =18 year age , either sex race . Women childbearing potential ( include woman less 1 year postmenopausal ) must use acceptable method birth control since least one month prior visit 1 ( e.g. , hormonal contraceptive , medically prescribe IUD , condom combination spermicide ) surgically sterilize ( e.g. , hysterectomy tubal ligation ) . Women childbearing potential counseled appropriate use birth control study . Subjects must general good health confirm medical history , physical examination ; i.e. , must free clinically significant disease ( chronic urticaria [ CU ] ) would interfere study evaluation . Subjects must understand able adhere dose visit schedule , agree complete questionnaire record accurately consistently daily diary symptom severity score , medication time , concomitant medication , adverse event . Subjects must history CU define least 6 week pruritus hive hive last less 24 hour occur least 2 day per week . Subjects must experience current CU flare hive present least 2 day week prior consent visit/visit 1 . Subjects must pruritus score &gt; =2 hive score &gt; =1 consent visit/Visit 1 12 hour consent visit/Visit 1 Subjects must score Overall Condition CU &gt; =2 consent visit/Visit 1 Visit 2 ( Baseline ) . Subjects must total pruritus score &gt; =11 sum morning ( AM ) evening ( PM ) ( reflective ) diary score 3 day prior Visit 2 ( Baseline ) plus morning score day Visit 2 Women childbearing potential must negative urine pregnancy test Visit 2 ( Baseline ) . Women pregnant nursing . Subjects observed designate washout period prohibit medication Subjects asthma Subjects drug food allergy manifest skin reaction 1 year prior consent visit / visit 1 Subjects atopic dermatitis Subjects urticaria primarily due physical urticaria know etiology ( basis clinical history physical examination ) . Subjects CU unresponsive antihistamine . Subjects regular treatment NSAIDs . Subjects hospitalize worsen CU within 3 month prior Visit 1 ( Screening ) . Subjects history hypersensitivity Desloratadine excipients . Subjects previously enrol study ( i.e . assign treatment ) . Subjects staff personnel directly involve administration study . Subjects clinically significant metabolic , cardiovascular , immunologic , neurologic , hematologic , neoplastic , gastrointestinal , cerebrovascular , respiratory disease , disorder , judgment Investigator , may interfere study evaluation affect subject safety . Subjects history psychosis , antagonistic personality , poor motivation , hypochondriasis , emotional intellectual problem likely limit validity consent participate study . Subjects history noncompliance medication treatment protocol . Subject treat investigational drug last 30 day prior baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>